Plexus (NASDAQ:PLXS) Beats Expectations in Strong Q2 CY2026, Provides Optimistic Revenue Guidance for Next Quarter

Plexus (NASDAQ:PLXS) reported Q2 CY2026 revenue of $1.30 billion, up 28.1% year on year, beating expectations by 5.8%. Non-GAAP EPS was $2.32, up from $1.90 a year earlier, and 8.5% above consensus. The company guided next-quarter revenue to $1.36 billion at the midpoint, about 6.5% above analysts’ view.

Original reporting
Published Jul 29, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Plexus (NASDAQ:PLXS) Beats Expectations in Strong Q2 CY2026, Provides Optimistic Revenue Guidance for Next Quarter — source image
Decision brief

The 30-second read

$PLXSBullishMed
01

Why it matters

Q2 revenue and non-GAAP EPS beat, combined with next-quarter revenue guidance above consensus, increases the probability of upward estimate revisions and supports a constructive near-term trading setup.

02

Market read

Traders can reassess PLXS’s near-term revenue and EPS trajectory using the quantified guidance midpoint and the stated beat versus consensus.

03

What to watch

The article lacks detailed backlog, program ramp timing, and margin outlook beyond the single-quarter guidance, which could limit how far the rerating goes.

Relevance 8/10Novelty 8/10Timing: after-hours/next-session reaction to Q2 results and next-quarter revenue guidance

Background

Plexus is an electronic manufacturing services provider serving aerospace/defense, healthcare, and industrial end markets.

Company-level read

Ticker impact

$PLXSBullishMedium confidence
Context

Plexus reported Q2 CY2026 revenue of $1.30B (+28.1% YoY) and guided next-quarter revenue to $1.36B midpoint, above expectations.

Expected impact

Likely positive bias for the next few sessions as traders reprice the guidance beat and margin/EPS trajectory.

Evidence & confidence

The article provides specific Q2 results and a quantified next-quarter revenue midpoint that is stated to be above analyst expectations, which is typically a direct driver of estimate revisions.

Market effects

A strong EMS quarter with upside revenue guidance can improve sentiment for aerospace/defense and industrial electronics outsourcing demand.

Primarily US-listed small/mid-cap industrial/EMS sentiment; limited direct regional spillover beyond US trading flows.

Read-through to global electronics manufacturing services demand, but the article is company-specific with no cross-region datapoints.

Counterpoint

The stock was described as flat immediately after results, suggesting the market may already have priced in the beat and guidance.

Key entities

  • Plexus

    Reported Q2 CY2026 results and provided next-quarter revenue guidance.

  • Todd Kelsey

    CEO who commented on record quarterly revenue and program launches.

Related articles

$PLXSHigh

PLEXUS CORP (PLXS): Results of Operations and Financial Condition

PLEXUS CORP (PLXS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Plexus Announces Fiscal Third Quarter Financial Results NEENAH, WI – July 29, 2026 - Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal third quarter ended July 4, 2026, and guidance for our fiscal fourth quarter ending October 3, 2026. • Reports record

$PAHCMedAI 8/10

Phibro Animal Health (PAHC) Sets 2027 Guidance, Is The Stock Still A Bargain?

Phibro Animal Health (PAHC) issued 2027 guidance, projecting net sales of $1.55b-$1.60b and net income of $122m-$132m. The company reported 2026 sales of $1.518b and net income of $99.72m. Analysts' price targets range from $38 to $58, with a consensus of $45.60, suggesting a 16.1% undervaluation. The stock has seen a 90-day return of 17.95% and a 3-year return above 200%.

$HONMed

Honeywell Is Now Three Companies. Here's Which Piece I'd Actually Own.

Honeywell has split into three companies: Honeywell Technologies (HON), Solstice Advanced Materials (SOLS), and Honeywell Aerospace (HONA). Honeywell Technologies, led by CEO Vimal Kapur, reported strong automation sector growth with 16% order increase and 10% earnings growth. Solstice Advanced Materials showed 11% sales growth and 23% EPS increase, while Honeywell Aerospace lowered guidance.

$PATHMed

Why UiPath Stock Plunged Today

UiPath (NYSE: PATH) shares fell after its Q2 fiscal 2027 earnings, despite revenue growth of 13% to $410M and adjusted operating income up 43% to $89M. CEO Daniel Dines highlighted the company's strategy of using AI where it adds value. Analyst Kingsley Crane downgraded the stock to 'hold', citing competitive threats from AI-powered rivals like Salesforce.